Bayer Healthcare has submitted its new eye drug to European regulators for approval to treat age-related macular degeneration (wet AMD). …

While many of its larger peers in the pharma sector are rushing to diversify into consumer health and generics, Bayer, …

Phase III data for a new age-related macular degeneration (wet AMD) treatment show it is as good as Lucentis, the …

